perifosine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allgood, SD; Brander, DM; Chen, Y; Davis, ED; Davis, PH; Friedman, DR; Gockerman, JP; Lanasa, MC; Matta, KM; Moore, JO; Sportelli, P; Volkheimer, AD; Weinberg, JB | 1 |
| Friedman, DR; Hagiopian, MM; Holohan, B; Huang, E; Lai, TP; Shay, JW; Wright, WE | 1 |
1 trial(s) available for perifosine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm Staging; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Signal Transduction; Treatment Outcome | 2014 |
1 other study(ies) available for perifosine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Perifosine as a potential novel anti-telomerase therapy.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Clinical Trials, Phase II as Topic; Enzyme Inhibitors; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Phosphorylcholine; Telomerase; Telomere; Xenograft Model Antitumor Assays | 2015 |